Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Abraçando o conceito pró-aging, Cetaphil lança uma linha completa de produtos para o rejuvenescimento saudável da pele


News provided by

Galderma

Apr 24, 2023, 13:53 ET

Share this article

Share toX

Share this article

Share toX

A nova linha foi desenvolvida com um complexo de ingredientes que promovem ação pró-colágeno e antioxidante*, garantindo uma pele rejuvenescida em 2 semanas**

SÃO PAULO, 24 de abril de 2023 /PRNewswire/ -- A marca Cetaphil acaba de anunciar a chegada de produtos inovadores com base em estudos científicos avançados. A linha Healthy Renew conta com quatro produtos e uma combinação poderosa de ingredientes que vão promover uma revolução na rotina de skincare dos pacientes e consumidores. O Brasil é o primeiro mercado do mundo a lançar a linha e abraçar esse movimento.

Continue Reading

Alinhada com o conceito 'pró-aging', que defende o rejuvenescimento saudável e consciente, as novidades de Cetaphil Healthy Renew são voltadas para a beleza e a saúde do cuidado facial. Com uma combinação perfeita de ingredientes como peptídeos purificados, extrato de arroz e extrato de Edelweiss, a linha proporciona uma pele rejuvenescida e mais saudável em 2 semanas¹.

"O movimento pró-aging enaltece a vida e celebra as marcas de cada história de pele. Nosso objetivo com o lançamento da linha Cetaphil Healthy Renew é promover a aceitação e o contentamento com o seu próprio reflexo, em todos os estágios da vida", afirma Claudia Paz, gerente de estratégia digital & DTC da BU de Consumo e Prescrição da Galderma.

De acordo com a dermatologista Dra. Renata Bertino (CRM 795771-RJ), os cuidados com o rejuvenescimento da pele podem começar desde cedo. "Os pacientes podem iniciar o uso de produtos com o conceito 'pró-aging' a partir dos 30 anos para garantir um rejuvenescimento saudável, a partir dos 40 para cuidar desse rejuvenescimento e a partir dos 50 para tratar e reverter questões ligadas à saúde da pele durante o envelhecimento natural", explica a médica.

A Solução micelar – Tripla ação chega para promover a limpeza profunda da pele, melhorando sua textura2 e hidratação por 24h3, além da luminosidade, firmeza e elasticidade da pele.4-5

O Sérum facial promove rejuvenescimento e aparência mais saudável em 2 semanas6, além de reduzir as rugas e linhas finas7. Os peptídeos purificados de sua composição promovem ação pró-colágeno e antioxidante8.

Já o Sérum olhos reduz as rugas e linhas finas ao redor dos olhos, tem rápida absorção9 e diminui as olheiras e sinais de fadiga10.  Sua fórmula conta com Pantenol, componente que melhora a barreira cutânea protegendo contra a irritação da pele11.

Além dos séruns, a nova família Cetaphil Healthy Renew apresenta o Creme Noturno. O produto deixa a pele mais iluminada*, uniforme12 e reduz linhas finas13, tudo isso para melhorar a textura14 da pele para o dia a dia.

A linha está disponível nos principais e-commerces do Brasil. Acesse: Beleza na Web e Época Cosméticos e confira todas as opções. Vale ressaltar que, antes de iniciar os cuidados com Cetaphil, é importante seguir as orientações de um dermatologista.

 1.Galderma Data on file: RD.27.SPR.202958 / P23242, RD.27.SPR.202953 / P2275 / P23233, RD.27.SPR.202962/P23264 & RD.27.SPR.202983/P2330  | 97% dos usuários perceberam redução das linhas finas após 28 dias de uso, (Estudo realizado com 39 participantes)|100% dos usuários reportaram que a pele parece estar mais firme (Estudo realizado com 40 participantes) | 98% dos usuários sentiram e perceberam visualmente melhora da elasticidade da pele (Estudo realizado com 40 participantes)| 2. Data on file: RD.27.SPR.202980/P2330 & RD.27.SPR.203084 - P2275 | 73% dos usuários relataram que o produto ajuda a uniformizar e suavizar a textura da pele. Estudo realizado com 40 participantes. | 3.  Data on file RD.27.SPR.202958_Asian subjects (FIL 1710) - S chagen, SK. Topical Peptide Treatments with EffectiveAnti-Aging Results Cosmetics 2017 4, 16;  doi:10.3390/cosmetics4020016 | Estudo realizado com 45 participantes, durante 56 dias de uso | 4. Data on file: RD.27.SPR.202953 - P2275
273% dos usuários relataram que o produto ajuda a uniformizar e suavizar a textura da pele.*
(estudo realizado com 40 voluntários, n=40)
3FÓRMULA
4-5 IN-USE TEST UNDER DERMATOLOGICAL CONTROL RD.27.SPR.202983/P2330
6conforme CL-002305 Pele rejuvenescida e mais saudável em 2 semanas.  *Em uma pesquisa qualitativa a melhora foi observada em todos os atributos de graduações clínicas foi relacionada ao rejuvenescimento, enquanto os atributos brilho, uniformidade, luminosidade e textura foram relacionados a uma pele mais saudável.
7IN-USE TEST UNDER DERMATOLOGICAL AND OPHTHALMOLOGICAL CONTROLS - RD.27.SPR.202958/ P2324
8Schagen, SK. Topical Peptide Treatments with Effective
Anti-Aging Results Cosmetics 2017, 4, 16; doi:10.3390/cosmetics4020016
9Claim de percepção conforme CL-002333: 90% dos usuários consideraram que o produto absorve rapidamente.*(estudo realizado com 40  voluntários, n=40)
10IN USE TEST UNDER DERMATOLOGICAL AND OPHTALMOLOGICAL CONTROLS, WITH EVALUATION OF THE EFFICACY OF A PRODUCT APPLIED UNDER NORMAL CONDITIONS OF USE – MULTICENTRIC STUDY - RD.27.SPR.202953 - P2275
11Bissett DL. Common cosmeceuticals. Clin Dermatol. 2009 Sep-Oct;27(5):435-45. doi:10.1016/j.clindermatol.2009.05.006. PMID: 19695474
12IN USE TEST UNDER DERMATOLOGICAL CONTROL - RD.27.SPR.202962/P2326
1397% dos usuários perceberam redução das linhas finas após 28 dias de uso. *
(estudo realizado com 40  voluntários, n=42) e 97% dos usuários perceberam redução das rítides.* (estudo realizado com 40  voluntários, n=42)
*conforme CL-002321: *98% dos usuários perceberam a pele mais brilhante/iluminada.*
(estudo realizado com 40  voluntários, n=42
14Cl-002454 IN USE TEST UNDER DERMATOLOGICAL CONTROL - RD.27.SPR.202962/P2326

Sobre a Galderma
A Galderma é a empresa líder na categoria exclusivamente dedicada à dermatologia, presente em aproximadamente 90 países. Fornecemos um portfólio inovador e baseado na ciência de marcas e serviços premium que abrangem todo o espectro do mercado de dermatologia em rápido crescimento, por meio de Estética Injetável, Dermocosméticos e Dermatologia Terapêutica. Desde nossa fundação em 1981, dedicamos nosso foco e paixão ao maior órgão do corpo humano – a pele – atendendo às necessidades individuais de consumidores e pacientes com resultados superiores em parceria com profissionais de saúde. Estamos avançando a dermatologia para cada história de pele, porque entendemos que a pele em que estamos molda nossas histórias de vida. Para mais informações: www.cetaphil.com.br.

Foto - https://mma.prnewswire.com/media/2061748/cetaphill0758copiar.jpg

FONTE Galderma

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the establishment of its new U.S. headquarters in Miami, Florida,...

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of "Scratch Resistance," its new broadcast advertisement...

More Releases From This Source

Explore

Cosmetics and Personal Care

Cosmetics and Personal Care

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

Fitness/Wellness

Fitness/Wellness

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.